Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT02494323Not ApplicableCompleted

Evaluation of Dual Channel vs. Single Channel FES for Dropfoot

Role: lead

NCT02738242Not ApplicableUnknown

Evaluation of Usability and Human Factors in the Novus System

Role: lead

NCT01237860Phase 3Completed

Evaluation of the Safety and Performance of the NESS L300 Plus System

Role: collaborator

All 3 trials loaded